Drug recall · April 10, 2024
Cyclophosphamide for Injection recall
Why: Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cyclophosphamide for Injection, USP, 500mg/vial, Lyophilized, Cytotoxic Agent, Single Dose Vial for Intravenous Use, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc. Big Flats, NY 14814, NDC # 39822-0250-01.
- Lots / codes
Lot #: CIC1-23001 A, Exp. 08/30/2026
- Quantity
- 1283 vials
- Company
- X-Gen Pharmaceuticals Inc., Horseheads, NY
- Distribution
- Nationwide in the US
- Initiated
- April 2, 2024 · Voluntary: Firm initiated
- Classified
- April 4, 2024
- Reported
- April 10, 2024
- Ended
- September 30, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cyclophosphamide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.